Care Innovation
Which Care Delivers Better Health?
How emerging therapies, precision biology, and unified care models can address gaps in today’s benefits—and what evidence demonstrates better outcomes and value.
Invite Only And Off The Record Event. For Senior Benefits Leaders
Are your programs reaching the people who need them, improving health, and justifying their cost?
Healthcare benefits are at an inflection point. Leaders are reassessing decisions made during COVID as AI, precision biology, and emerging therapies like GLP-1s and HRT create new possibilities—and new purchasing pathways.
Half-Life:100 brings senior benefits leaders together with physicians, scientists, and AI innovators to examine the evidence, compare experience, and decide what deserves a place in the next generation of healthcare benefits.
April 14th–15th, 2027. Silverado Resort, Napa Valley
Who's At The Table
Every seat is intentional.
We're assembling 40 senior benefits leaders, from government to Fortune 50 employers across retail, manufacturing, technology, and finance, alongside leading physicians, scientists, and AI innovators. Every seat brings a perspective on the decisions ahead: cost, access, member experience, and what is worth changing.
Benefits leaders
Leaders across government and major employers, shaping what comes next.
Physicians and scientists
AI innovators
The Room
Half-Life:100 is an invitation-only working gathering. Every person contributes—as a panelist, a lightning speaker, or a table lead. Senior benefits leaders, physicians, scientists, and AI innovators work through the choices shaping healthcare benefits for 2028 and beyond. No exhibit hall. No passive audience. No sales pitches.
What's said in Napa is said off the record, by design. That's the whole invitation.
What We Will Accomplish Together
Together, we will develop an evidence-informed strategic perspective and practical playbook for 2028 and beyond.
We will examine where today’s care portfolios fall short, which innovations merit investment, and how to hold partners accountable for meaningful engagement, clinical improvement, and financial value.
The goal: clearer decisions about what to keep, consolidate, renegotiate, replace—or introduce.
Care Innovation
How emerging therapies, precision biology, and unified care models can address gaps in today’s benefits—and what evidence demonstrates better outcomes and value.
Artificial Intelligence
Where AI can improve access, care delivery, navigation, and administration—and how to evaluate real-world performance before investing.
Human Experience
Why people start, stay with, or leave care programs—and how benefits design and the member experience can support meaningful participation and lasting improvement.
Across all three, we will examine how vendor contracts should reflect these goals: what to measure, how to verify results, and how to balance payment for care delivered with engagement commitments and outcome guarantees.
The Experience
The conversation begins before Napa, as you meet the group and explore the questions ahead. In person, working sessions, personal health insights, and hosted experiences create space for candid exchange—from the first introductions to the last glass at Hall Winery.
3 months out
An at-home genetic, gut microbiome, and blood test arrives at your door — a few minutes, done from home.
1 month out
A virtual webinar to get to know the room before you're in it — the faces, the themes, the questions on the table.
Apr 14 · Midday
Check in at Silverado Resort — the golf course and the spa are yours to use around the program.
Apr 14 · Afternoon
Receive your testing results, private to you and yours to keep — and meals personalized to your biology from here on.
Apr 14–15
Dig into the hardest questions with industry peers — on panels, over long breaks, and at hosted dinners.
Apr 14 & 15
Opening and closing keynotes from physicians and scientists educating the room on the now—and the frontier—of care and healthspan.
Apr 15
The room closes with a private hosting and tasting at Hall Winery — +1s welcome.
The Arc
Predict the forces reshaping healthcare benefits. Personalize care and the member experience. Participate in the decisions that define what comes next.
Unified line of thinking, carried across a day and a half — not twelve disconnected breakouts stitched into an agenda. Roughly a quarter of the clock is left unprogrammed, on purpose: the sessions make the case, the long breaks are where it actually lands.
Act I · Predict
Wed, Apr 14
The Science and Biology of What Comes Next
Where are GLP-1 therapies taking us? Explore evolving science, treatment options, individual response, and long-term care—alongside the behavior, coverage, and budget decisions that will shape their impact.
What can genetics, the gut microbiome, and blood biomarkers reveal about risk, treatment response, and personalized care? Examine the science, clinical usefulness, and value of testing: when does knowing more lead to better decisions and better health?
What could chronic care look like when metabolic, digestive, inflammatory, and hormonal health are considered together? Explore how emerging biology could reshape today’s condition-by-condition benefits—and how to evaluate its effectiveness.
Acts II–III · Personalize / Participate
Thu, Apr 15
Turning the Frontier Into Better Care
Care at Zero — how AI, emerging therapies, and new care models could change the cost of care—and what that means for benefits strategy.
Working discussions
What could care become when support is available between appointments and informed by a person’s biology, symptoms, and progress? Examine the possibilities for AI, the role of clinicians, and the evidence needed to move from promising demonstrations to dependable care.
How do we turn biological insight and effective treatments into habits people can sustain? Explore the interplay of medication, food, motivation, life circumstances, and member experience—and what meaningful engagement should look like.
How should employers evaluate and pay for the next generation of care? Examine the value of advanced testing, emerging therapies, and AI—and how contracts can connect investment to access, sustained participation, clinical effectiveness, and verifiable financial value.
Translate the science and discussion into practical choices: what to keep, consolidate, renegotiate, replace, or introduce—and what evidence will guide each decision.
In this shared working session, tables share their read-outs with the room.
If you'd like to be considered for the room, tell us a bit about yourself and how you'd like to contribute: a panel seat, a lightning talk or leading a table.
What Is Half-Life:100
Healthcare benefits leaders face decisions that reach far beyond any single condition, therapy, or technology. Half-Life:100 creates space to step back, compare evidence and experience, and consider how healthcare should be designed, delivered, and paid for.
Convened by Digbi Health, this initiative brings senior benefits leaders together with physicians, scientists, and AI innovators to develop an evidence-informed strategic perspective and playbook for 2028 and beyond. Our ambition is to help this community make clearer choices for a more effective, accessible, and sustainable healthcare future.